DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting Nov 22, 2013
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology Nov 14, 2013
DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers Oct 21, 2013
DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting Oct 15, 2013
DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients Oct 9, 2013
DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV Sep 19, 2013
DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com Sep 16, 2013
DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com September 12th Sep 9, 2013
DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China Sep 9, 2013
DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference Sep 3, 2013
